Offer - Urjas Oil for just ₹ 1 X
Nebzmart FB 0.5mg Smartules 2ml (7) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Nebzmart FB 0.5mg Smartules 2ml (7) safe for pregnant women?
Pregnant women may experience moderate side effects from Nebzmart FB Smartules. It is best to stop taking Nebzmart FB Smartules immediately and inform your doctor if you notice any discomfort.
Is the use of Nebzmart FB 0.5mg Smartules 2ml (7) safe during breastfeeding?
Nebzmart FB Smartules may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Nebzmart FB Smartules, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Nebzmart FB Smartules.
What is the effect of Nebzmart FB 0.5mg Smartules 2ml (7) on the Kidneys?
Nebzmart FB Smartules does not damage the kidneys.
What is the effect of Nebzmart FB 0.5mg Smartules 2ml (7) on the Liver?
Nebzmart FB Smartules does not damage the liver.
What is the effect of Nebzmart FB 0.5mg Smartules 2ml (7) on the Heart?
Nebzmart FB Smartules has very mild side effects on the heart.
Nebzmart FB 0.5mg Smartules 2ml (7) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Nebzmart FB 0.5mg Smartules 2ml (7) unless your doctor advises you to do so -
Is this Nebzmart FB 0.5mg Smartules 2ml (7) habit forming or addictive?
No, you will not get addicted to Nebzmart FB 0.5mg Smartules 2ml (7).
Is it safe to drive or operate heavy machinery when consuming?
Nebzmart FB 0.5mg Smartules 2ml (7) does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Nebzmart FB 0.5mg Smartules 2ml (7) only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Nebzmart FB 0.5mg Smartules 2ml (7) in mental disorders is not effective.
Interaction between Food and Nebzmart FB 0.5mg Smartules 2ml (7)
Taking Nebzmart FB 0.5mg Smartules 2ml (7) with food is safe.
Interaction between Alcohol and Nebzmart FB 0.5mg Smartules 2ml (7)
Taking Nebzmart FB 0.5mg Smartules 2ml (7) with alcohol can have severely harmful effects on your health.
No, Nebzmart FB Smartules does not cause hair loss (alopecia). It has not been reported by the patients who are taking this drug. If you are experiencing excessive hair loss after taking this drug then it might be due to some other reason and you are advised to discuss it with your doctor.
No, Nebzmart FB Smartules does not cause weight loss. It has not been reported by the patient who is taking this drug. If you are experiencing any unusual weight loss after taking this drug then it might be due to some other reason and you are advised to discuss it with your doctor.
Yes, Nebzmart FB Smartules is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as a headache, sore throat, and runny nose. If you experience any discomfort after taking this medicine then inform your doctor immediately and follow his/her instructions.
Yes, Nebzmart FB Smartules is a steroid. It belongs to the class of drug known as the corticosteroids. It is used to prevent asthmatic attacks.
Yes, you can take Nebzmart FB Smartules after albuterol (salbutamol). No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
Product Description [Internet]: SYMBICORT. AstraZeneca